0001477932-23-000574.txt : 20230127 0001477932-23-000574.hdr.sgml : 20230127 20230127130659 ACCESSION NUMBER: 0001477932-23-000574 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221219 FILED AS OF DATE: 20230127 DATE AS OF CHANGE: 20230127 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Siokas Grigorios CENTRAL INDEX KEY: 0001660125 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-41308 FILM NUMBER: 23561217 MAIL ADDRESS: STREET 1: 5 AG. GEORGIOU STR., PILEA CITY: THESSALONIKI STATE: J3 ZIP: TK57001 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cosmos Health Inc. CENTRAL INDEX KEY: 0001474167 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] IRS NUMBER: 270611758 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 141 W. JACKSON BLVD STREET 2: SUITE 4236 CITY: CHICAGO STATE: IL ZIP: 60604 BUSINESS PHONE: 312-536-3102 MAIL ADDRESS: STREET 1: 141 W. JACKSON BLVD STREET 2: SUITE 4236 CITY: CHICAGO STATE: IL ZIP: 60604 FORMER COMPANY: FORMER CONFORMED NAME: Cosmos Holdings Inc. DATE OF NAME CHANGE: 20140106 FORMER COMPANY: FORMER CONFORMED NAME: PRIME ESTATES & DEVELOPMENTS INC DATE OF NAME CHANGE: 20091008 4/A 1 form4a.xml FORM 4 A X0306 4/A 2022-12-19-05:00 2022-12-21-05:00 false 0001474167 Cosmos Health Inc. COSM 0001660125 Siokas Grigorios 5 AG. GEORGIOU STR., PILEA THESSALONIKI J3 TK57001 GREECE true true true false Chief Executive Officer Common Stock, $.001 par value 2022-12-19-05:00 2022-12-19-05:00 4 P false 260870 11.50 A 1130774 D These shares were purchased by Mr. Siokas in a registered direct offering pursuant to the Company's "shelf" registration statement on Form S-3 (No. 333-267550) declared effective by the SEC on December 15, 2022. All share and per share amounts reflect a 1 for 25 reverse stock split effected on December 15, 2022 with the Secretary of State of Nevada. Remarks: This amendment is being filed pursuant to Amendment No. 1 to the Securities Purchase Agreement dated as of December 19, 2022 filed by the issuer on January 17, 2023. Under the amendment, Mr. Siokas delivered back to the issuer warrants to purchase 260,870 shares of common stock which were voided. /s/ Grigorios Siokas 2023-01-27-05:00